SCHEMBL703423

SCHEMBL703423

C[Si](C)(Cl)CCC[Si](C)(C)Cl

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL706918 0.92 ALDH1A1 (0.39) ALDH1A1
SCHEMBL21811651 0.89 ALDH1A1 (0.31) ALDH1A1
SCHEMBL21811695 0.89 ALDH1A1 (0.31) ALDH1A1
SCHEMBL21811894 0.89 ALDH1A1 (0.31) ALDH1A1
SCHEMBL5925009 0.89 ALDH1A1 (0.31) ALDH1A1
SCHEMBL8158855 0.88 ALDH1A1 (0.36) ALDH1A1
SCHEMBL175548 0.88 ALDH1A1 (0.36) ALDH1A1
SCHEMBL8166184 0.88 ALDH1A1 (0.36) ALDH1A1
SCHEMBL8166662 0.88 ALDH1A1 (0.36) ALDH1A1
SCHEMBL8169552 0.88 ALDH1A1 (0.36) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11670512-B2 Selective deposition on silicon containing surfaces VERSUM MATERIALS US, LLC (US) 2023-06-06 US claimed
CN-115591571-A Modification method for preparing cyclohexanol HZSM-5catalyst by direct hydration of cyclohexene 神马实业股份有限公司(CN) 2023-01-13 CN claimed
US-20220195238-A1 CHEMICALLY HOMOGENEOUS SILICON HARDMASKS FOR LITHOGRAPHY BREWER SCIENCE, INC. 2022-06-23 US claimed
US-20210118684-A1 SELECTIVE DEPOSITION ON SILICON CONTAINING SURFACES VERSUM MATERIALS US, LLC 2021-04-22 US claimed
US-20100228038-A1 PROCESSES FOR THE PRODUCTION OF POLYCYCLIC FUSED RING COMPOUNDS FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2010-09-09 US claimed
US-7667055-B2 Processes for the production of polycyclic fused ring compounds FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2010-02-23 US claimed
US-7358378-B2 Processes for the preparation of paclitaxel FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2008-04-15 US claimed
US-20060281934-A1 Processes for the production of polycyclic fused ring compounds FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2006-12-14 US claimed
US-20060281933-A1 Processes for the preparation of paclitaxel FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2006-12-14 US claimed
US-20060281932-A1 Processes for the preparation of docetaxel FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2006-12-14 US claimed
EP-4570877-A1 SURFACE TREATMENT AGENT DAIKIN INDUSTRIES, LTD. (JP) 2025-06-18 EP disclosed
EP-4083046-B1 METHOD FOR PREPARING HALOSILANE COMPOUNDS SHINETSU CHEMICAL CO (JP) 2025-03-26 EP disclosed
CN-119698451-A Surface treating agent 大金工业株式会社 2025-03-25 CN disclosed
EP-4509551-A1 SURFACE TREATMENT AGENT DAIKIN INDUSTRIES, LTD. (JP) 2025-02-19 EP disclosed
WO-2025028568-A1 SURFACE TREATMENT AGENT ダイキン工業株式会社 2025-02-06 WO disclosed
US-20060281934-A1 Processes for the production of polycyclic fused ring compounds FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2006-12-14 US disclosed
US-20060281933-A1 Processes for the preparation of paclitaxel FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2006-12-14 US disclosed
US-20050118742-A1 Method for reducing the adhesive properties of MEMS and anti-adhesion-coated device ROBERT BOSCH GMBH (DE) 2005-06-02 US disclosed
US-6010974-A Carbon and/or silicon bridged binuclear metallocene catalyst for styrene polymerization CHEIL INDUSTRIES, INC. (KR) 2000-01-04 US disclosed
US-4766037-A Photodegradable microcapsules FUJI PHOTO FILM CO., LTD. (JP) 1988-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060281934-A1 Processes for the production of polycyclic fused ring compounds COASY, PARG, PIN4 ALDH1A1 4039/4885
US-20060281933-A1 Processes for the preparation of paclitaxel PDCD10, PDS5B, CASP10 ALDH1A1 1118/4885
US-20100228038-A1 PROCESSES FOR THE PRODUCTION OF POLYCYCLIC FUSED RING COMPOUNDS COASY, PARG, PIN4 ALDH1A1 4039/4885
US-20060281932-A1 Processes for the preparation of docetaxel PDCD10, PDS5B, DHCR7 ALDH1A1 954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.